PUR0200

DRUG2 trials

Sponsors

Pulmatrix Inc.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Healthy

Phase 1

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

CompletedNCT01921712

Pulmatrix Inc.Chronic Obstructive Pulmonary Disease (COPD)

Start: 2013-07-31End: 2013-12-31Updated: 2014-03-18

A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects

CompletedNCT02671825

Pulmatrix Inc.Healthy

Start: 2016-01-31End: 2016-03-31Updated: 2016-11-11